ADC · HER2+ 유방암

ADCBiologicstaleRemeGenApproved

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Combined With Fruquintinib)

HER2; Colorectal Cancer · HER2

#HER2#ADC#Approved#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 ACTIVE

ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin and Toripalimab)

Muscle Invasive Bladder Cancer; HER2 Expression · HER2

ADCBiologicstaleRemeGenPhase 2

임상시험 1상태 ACTIVE

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Radiotherapy)

HER2-expressing High-risk or Very High-risk NMIBC Without Visible Foci of Disease After TURBT · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with fruquintinib and Tislelizumab)

HER2-positive Gastric Cancer; Immunotherapy · HER2

ADCBiologicstaleRemeGenPreclinical

임상시험 1상태 ACTIVE

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin plus pyrotinib or naratinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab vedotin + Sintilimab + Multimodality radiotherapy)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleThe First Affiliated Hospital w…Phase 2

Disitamb Vedotin ,pyrotinib (Disitamb Vedotin ,pyrotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

E1: SHR-A1811 (E1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

E2: SHR-A1811 with everolimus (E2: SHR-A1811 with everolimus)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

ADCBiologicstaleInstitut CuriePhase 3

Endocrine therapy combined with the local treatment of FES-negative lesions (Endocrine therapy combined with the local treatment of FES-negative lesions)

Breast Carcinoma · Breast Carcinoma

#BreastCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Endoxifen + Abemaciclib (Endoxifen + Abemaciclib)

Breast Neoplasms; Breast Cancer · HER2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

F1: TROP2 ADC (F1: TROP2 ADC)

Triple-negative Breast Cancer · TROP2

ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

Felmetatug Vedotin (Felmetatug Vedotin)

Ovarian Neoplasms; Peritoneal Neoplasms · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

임상시험 1상태 DISCONTINUED

ADCBiologicstaleSun Yat-Sen Memorial Hospital o…Phase 3

Fluorizoparib (Fluorizoparib)

Metastatic Breast Cancer; HRD-Positive/HER2-Negative Advanced Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4

Fluzoparib (Fluzoparib)

Breast Neoplasm; Breast Cancer · HER2

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

G1: SHR-A1811 (G1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

GSK 5733584 (GSK 5733584)

Breast Neoplasms; Breast Cancer · HER2

ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

HB1901 (HB1901)

Advanced Breast Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX43 DOSE1 IN 1L TNBC (HLX43 DOSE1 IN 1L TNBC)

Breast Cancer (Triple Negative Breast Cancer (TNBC)) · Breast Cancer (Triple Negative Breast Ca

#BreastCancerTripleNegativeBreast#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1